TuHURA Biosciences, Inc.
HURA
$1.81
-$0.03-1.63%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 108.00% | 63.44% | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 73.94% | 45.16% | -- | -- | -- |
| Operating Income | -73.94% | -45.16% | -- | -- | -- |
| Income Before Tax | -59.44% | -60.20% | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -59.44% | -60.20% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -59.44% | -60.20% | -- | -- | -- |
| EBIT | -73.94% | -45.16% | -- | -- | -- |
| EBITDA | -75.10% | -46.12% | -- | -- | -- |
| EPS Basic | 53.85% | -20.36% | -- | -- | -- |
| Normalized Basic EPS | 57.69% | -1.18% | -- | -- | -- |
| EPS Diluted | 53.88% | -20.25% | -- | -- | -- |
| Normalized Diluted EPS | 57.69% | -1.18% | -- | -- | -- |
| Average Basic Shares Outstanding | 73.08% | 54.24% | -- | -- | -- |
| Average Diluted Shares Outstanding | 73.08% | 54.24% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |